S. Kanamitsu

发表

Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

Yuichi Sugiyama, Motohiro Kato, Koji Chiba, 2002, AAPS PharmSci.

Prediction of in vivo drug-drug interactions based on mechanism-based inhibition from in vitro data: inhibition of 5-fluorouracil metabolism by (E)-5-(2-Bromovinyl)uracil.

Y. Sugiyama, K. Muro, H. Okuda, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Quantitative Prediction of In Vivo Drug-Drug Interactions from In Vitro Data Based on Physiological Pharmacokinetics: Use of Maximum Unbound Concentration of Inhibitor at the Inlet to the Liver

Yuichi Sugiyama, Kiyomi Ito, Y. Sugiyama, 2000, Pharmaceutical Research.

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport.

Y. Sugiyama, Kiyomi Ito, T Iwatsubo, 1998, Annual review of pharmacology and toxicology.

Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.

Y. Sugiyama, Kiyomi Ito, T. Iwatsubo, 1998, Pharmacological reviews.

Induction of DNA Recombination by Activated 3‐Amino‐1‐methyl‐5H‐pyrido[4,3‐b]indole

H. Hayatsu, K. Negishi, H. Ikeda, 1995, Japanese journal of cancer research : Gann.

Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.

Kiyomi Ito, Kiyomi Ito, Tomoo Itoh, 2003, Drug metabolism and disposition: the biological fate of chemicals.

Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.

Y. Sugiyama, S. Imaoka, C. Tyson, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4

Y. Sugiyama, Kiyomi Ito, C. Tyson, 2000, Pharmaceutical Research.

Quantitative Prediction of Drug Interation Involving Metabolism and Transport in the Liver

Y. Sugiyama, Kiyomi Ito, Y. Kato, 2000 .